• Issue

    The Prostate: Volume 83, Issue 2

    i, 133-203
    February 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

COVER

Free Access

Cover Image: Volume 83 Issue 2

Siyuan Cheng PhD,  Xiuping Yu PhD, 
  • Page: i
  • First Published: 19 December 2022
Cover Image: Volume 83 Issue 2 Volume 83 Issue 2, 2023

Cover Caption: The cover image is based on the Original Article CTPC, a combined transcriptome data set of human prostate cancer cell lines by Siyuan Cheng PhD et al., https://doi.org/10.1002/pros.24448

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 133-134
  • First Published: 19 December 2022

ORIGINAL ARTICLES

Long-term outcomes of radical prostatectomy versus low-dose-rate brachytherapy in patients with intermediate-risk prostate cancer: Propensity score matched comparison

Fumihiko Urabe MD, PhD,  Kenta Miki MD, PhD,  Takahiro Kimura MD, PhD,  Hiroshi Sasaki MD, PhD,  Kojiro Tashiro MD,  Kosuke Iwatani MD,  Akihiro Matsukawa MD,  Koichi Aikawa MD,  Yuki Tsusumi MD,  Midoriko Morikawa MD,  Kyosuke Minato MD,  Shun Sato MD, PhD,  Hiroyuki Takahashi MD, PhD,  Manabu Aoki MD, PhD,  Shin Egawa MD, PhD, 
  • Pages: 135-141
  • First Published: 29 September 2022

18F-DCFPyL positron emission tomography/magnetic resonance imaging-guided ultrasound fusion biopsy is an identical pathway in prostate cancer diagnosis

Shaoxi Niu MD, PhD,  Yachao Liu MM,  Xiaohui Ding MM,  Yong Xu MM,  Hongkai Yu MM,  Xiaodong Feng MB,  Xiao Chang MD,  Haiyi Wang MD, PhD,  Jinhang Li MM,  Huijie Gong MM,  Liyan Ao MB,  Jiajin Liu MB,  Mu Lin MD, PhD,  Baojun Wang MD, PhD,  Xin Ma MD, PhD,  Baixuan Xu MM,  Xu Zhang MD, PhD, 
  • Pages: 142-150
  • First Published: 25 October 2022

Initial outcomes and insights from a novel high-risk prostate cancer screening clinic

Jonathan B. Harper BA,  Samantha E. Greenberg MS, MPH, CGC,  Trevor C. Hunt MD,  Kathleen A. Cooney MD,  Brock B. O'Neil MD, 
  • Pages: 151-157
  • First Published: 07 October 2022

CTPC, a combined transcriptome data set of human prostate cancer cell lines

Siyuan Cheng PhD,  Xiuping Yu PhD, 
  • Pages: 158-161
  • First Published: 07 October 2022

Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy

Marco Oderda MD, PhD,  Simone Albisinni MD,  Daniel Benamran MD,  Giorgio Calleris MD,  Mauro Ciccariello MD,  Alessandro Dematteis MD,  Romain Diamand MD,  Jean-Luc Descotes MD,  Gaelle Fiard MD, PhD,  Valerio Forte MD,  Alessandro Giacobbe MD,  Alessandro Marquis MD,  Giancarlo Marra MD,  Aurel Messas MD,  Giovanni Muto MD,  Alexandre Peltier MD,  Leire Rius MD,  Giuseppe Simone MD, PhD,  Thierry Roumeguere MD,  Riccardo Faletti MD,  Paolo Gontero MD, 
  • Pages: 162-168
  • First Published: 19 October 2022

Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience

Swayamjeet Satapathy MD,  Chandan K. Das DM,  Piyush Aggarwal MBBS,  Ashwani Sood DNB,  Ashwin S. Parihar MD,  Shrawan K. Singh MCh,  Bhagwant R. Mittal MD, 
  • Pages: 169-178
  • First Published: 19 October 2022

Proteoglycans orchestrate remodeling of prostatic cytoarchitecture after androgenic blockade in old gerbils

Silvana G. P. Campos PhD,  Bianca F. Gonçalves PhD,  Thalles Fernando Rocha Ruiz MSc,  Ellen Cristina R. Leonel PhD,  Daniele L. Ribeiro PhD,  Luiz Roberto Falleiros Junior MSc,  Rejane M. Goes PhD,  Sebastião R. Taboga PhD, 
  • Pages: 179-189
  • First Published: 19 October 2022

The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy

Emerson E. Lee AB,  Tanmay Singh MD,  Chen Hu PhD,  Misop Han MD,  Curtiland Jr. Deville MD,  Aditya Halthore MD,  Stephen Greco MD,  Phuoc Tran MD, PhD,  Theodore DeWeese MD,  Daniel Y. Song MD, 
  • Pages: 190-197
  • First Published: 31 October 2022

Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study

Takuya Oishi MD,  Shingo Hatakeyama MD,  Ryuji Tabata MD,  Daiji Fujimori MD,  Yohei Kawashima MD,  Ryuma Tanaka MD,  Noritaka Ishii MD,  Hikari Miura MD,  Toshikazu Tanaka MD,  Teppei Okamoto MD,  Hayato Yamamoto MD,  Takahiro Yoneyama MD,  Yasuhiro Hashimoto MD,  Satoshi Sato MD,  Chikara Ohyama MD, 
  • Pages: 198-203
  • First Published: 31 October 2022